MedTrace Logo

Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function

NCT06012669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-06-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.

Conditions

  • Immune Health

Interventions

DIETARY_SUPPLEMENT

High dose Human Lactoferrin

Dietary Supplement and Food Ingredient

DIETARY_SUPPLEMENT

Low dose Human Lactoferrin

Dietary Supplement and Food Ingredient

DIETARY_SUPPLEMENT

Active Control Bovine Lactoferrin

Dietary Supplement and Food Ingredient

Sponsors & Collaborators

  • Helaina Inc.

    collaborator INDUSTRY

  • Midwest Center for Metabolic and Cardiovascular Research

    lead OTHER

Principal Investigators

  • Kevin Maki, PhD · MB Clinical Research & Consulting, LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-06
Primary Completion
2023-12-27
Completion
2023-12-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06012669 on ClinicalTrials.gov